| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 14.15B | 14.09B | 14.54B | 14.66B | 14.85B | 12.52B |
| Gross Profit | 5.31B | 4.68B | 5.51B | 5.60B | 5.72B | 5.29B |
| EBITDA | 6.47B | 5.87B | 7.07B | 7.27B | 7.59B | 7.09B |
| Net Income | 3.05B | 2.89B | 3.47B | 3.67B | 4.11B | 3.78B |
Balance Sheet | ||||||
| Total Assets | 44.23B | 43.68B | 42.76B | 42.21B | 41.91B | 40.53B |
| Cash, Cash Equivalents and Short-Term Investments | 1.11B | 675.00M | 1.00B | 1.44B | 2.09B | 2.32B |
| Total Debt | 19.34B | 19.35B | 18.99B | 19.02B | 18.54B | 16.84B |
| Total Liabilities | 30.65B | 30.52B | 30.26B | 30.23B | 29.29B | 27.03B |
| Stockholders Equity | 13.57B | 13.16B | 12.50B | 11.98B | 12.63B | 13.50B |
Cash Flow | ||||||
| Free Cash Flow | 4.13B | 1.71B | 2.72B | 3.26B | 3.49B | 3.31B |
| Operating Cash Flow | 4.63B | 4.61B | 5.25B | 5.51B | 5.62B | 5.10B |
| Investing Cash Flow | -2.77B | -2.85B | -2.60B | -2.23B | -2.13B | -1.88B |
| Financing Cash Flow | -2.03B | -2.02B | -3.06B | -3.87B | -3.77B | -4.11B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | C$94.10B | 19.09 | 21.93% | 2.62% | 0.47% | 6.34% | |
72 Outperform | C$103.87B | 29.01 | 8.85% | 0.82% | 1.10% | 8.73% | |
72 Outperform | $163.35B | 21.15 | 40.38% | 2.32% | 1.87% | 9.41% | |
71 Outperform | $85.85B | 23.65 | 23.52% | 1.42% | -0.92% | -2.64% | |
71 Outperform | $71.89B | 29.53 | 17.43% | 1.85% | 0.60% | -19.01% | |
68 Neutral | $42.45B | 42.70 | 23.42% | 0.71% | -4.77% | -10.37% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |